The Organ-On-Chips Market size was valued at USD 62.62 million in 2022 and is expected to reach USD 386.29 million by 2030, at a CAGR of 29.74% from 2022 to 2030.

Organ-On-Chips Market Overview

Organ-on-a-chip is an artificial organ that mimics human organs. It is a multi-channel 3D microfluidic cell culture device that stimulates organ activity, mechanisms, and physiological responses. The combination of lab-on-a-chip (LOC) and cell biology allows researchers to examine human physiology in organ-specific settings, leading to the development of a new in vitro multicellular human bio model. The chip develops a narrow channel for blood and airflow in organs such as the lungs, gut, brain, liver, and heart. These devices are developed on a microchip containing continuously perfused chambers that are colonized with living cells to stimulate physiology at the tissue and organ level. An organ chip is a device used to grow internal organs with the help of silica gel.

Organ-on-a-chip is a potentially game-changing technology that combines tissue engineering and microfluidics. These technologies are expected to provide effective answers to long-standing questions in drug discovery and personalized disease treatment. It plays an important role in drug development research, thereby boosting the organ-on-a-chip industry.

The Organ-On-Chips Market has been recently published by Contrive Datum Insights to its huge database which helps to shape the future of businesses by making well-informed business decisions. It offers a comprehensive analysis of various business aspects such as global market trends, recent technological advancements, market size, shares, and new innovations. Furthermore, this analytical data has been compiled through data exploratory techniques such as primary and secondary research. Moreover, an expert team of researchers throws light on various static as well as dynamic aspects of the global Organ-On-Chips market.

Some of the key players profiled in the study are:

Different leading key players have been profiled to get better insights into the businesses. It offers detailed elaboration on different top-level industries which are functioning in global regions. It includes informative data such as company overview, contact information, and some significant strategies followed by key players: Mimetas (Netherlands), Emulate (US), InSphero (Switzerland), CN Bio Innovations, BioIVT, Kirkstall, Visikol, SynVivo, AxoSim, Nortis, and others.

Industry Development:

• In September 2022, in vitro model provider Emulate Inc. announced a new application of adeno-associated virus transduction for a liver-on-a-chip that helps researchers test the safety and efficacy of adeno-associated virus vectors in relevant liver models in Produces result in humans within weeks.
• In May 2021, CN Bio, the preeminent creators of single- and multi-organ microphysiology-on-a-chip systems that improve the accuracy and efficiency of drug discovery, revealed that their research relationship with the U.S. Food and Drug Administration has been extended by another three years .

What are the major Applications, Types, and Regions for the Organ-On-Chips Market?

By Type               

• Heart on chip
• Human on chip
• Intestine on chip
• Kidney on chip
• Liver on chip
• Lung on chip

On the Basis of End Use:

• Academic
• Research Institute
• Pharma companies

Organ-On-Chips Market Regional Insights:

North America is the largest market for Organ-On-Chips, accounting for 55.7% of the global market in 2020, followed by Europe, Asia, and the rest of the world. Looking ahead, Asia and the rest of the world will be the fastest-growing regions in the Organ-On-Chips market, with CAGRs of 34.1% and 33.0%, respectively, during 2020-2025. It will be followed by Europe and North America, which are expected to register CAGRs of 28.5% and 26.9%, respectively.
In 2021, North America is expected to dominate the market, followed by Europe, and is expected to continue during the forecast period. North America is attributed to factors such as the availability of new and advanced organ chips in the market and the presence of major pharmaceutical companies. Also, favorable government initiatives in terms of funding and planning for basic drug development and research. Many major players in the region are working towards better, more costly, and time-consuming drug discovery procedures by innovating and adapting organ-on-a-chip technology. Public and private research institutions are investing heavily in research. The Wyss Institute, for example, has received nearly $5.7 million in grants from the US FDA to use its organ-on-a-chip technology to test the body's physiological responses to radiation and evaluate drugs designed to combat those effects.

Geographically, the global Organ-On-Chips market has been analyzed in various regions such as North America, Europe, Asia-Pacific, Latin America, Middle East, and India. The global region is dominating this market in the upcoming future.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Organ-On-Chips Market Report Scope:

Report Attributes	Details
Growth Rate	CAGR of 29.74% from 2022 to 2030.
By Type	Heart on chip Human on chip Intestine on chip Kidney on chip Liver on chip Lung on chip
On the Basis of End Use:	Academic Research Institute Pharma companies
By Companies	Mimetas (Netherlands), Emulate (US), InSphero (Switzerland), CN Bio Innovations, BioIVT, Kirkstall, Visikol, SynVivo, AxoSim, Nortis
Regions and Countries Covered	North America: (US, Canada, Mexico, Rest of North America) Europe(Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe) Asia-Pacific (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific) The Middle East & Africa(Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa) Latin America(Brazil, Argentina, Rest of Latin America) Rest Of the World
Base Year	2022
Historical Year	2017 to 2022
Forecast Year	2023 to 2030

Frequently Asked Questions (FAQ) about the Organ-On-Chips market:

What is the CAGR of the global Organ-On-Chips market?

The Organ-On-Chips Market is growing at a CAGR of 29.74% during the forecast period.

Which region would offer high growth for vendors in the Organ-On-Chips market?

North America is the largest market for Organ-On-Chips, accounting for 55.7% of the global market in 2020.

Which Is the Most potential market segment?

By Type               

• Heart on chip
• Human on chip
• Intestine on chip
• Kidney on chip
• Liver on chip
• Lung on chip

Which are the top industry players in the Organ-On-Chips market?

Mimetas (Netherlands), Emulate (US), InSphero (Switzerland), CN Bio Innovations, BioIVT, Kirkstall, Visikol, SynVivo, AxoSim, Nortis

All of our reports are custom to your company's needs to some extent and we offer 5 hours of free consultation time with each report purchase, which will allow you to request any additional data to custom the report to your needs.